Another Positive Study of Ovarian Carcinoma

Czech version

Authors: Josef Chovanec
Authors‘ workplace: Oddělení Gynekologické onkologie, MOÚ Brno
Published in: Klin Onkol 2012; 25(5): 386
Category: Oncology Highlights

Sources

1. ÚZIS ČR. NOR ČR. Novotvary 2009 ČR. ÚZIS ČR, NOR ČR 2012. Dostupné z: http://www.uzis.cz/publikace/novotvary-2009.

2. Burger RA, Brady MF, Bookman MA et al. Gynecologic Oncology Group. Incorporation of bevacizumab in the primary treatment of ovarian cancer. N Engl J Med 2011; 365(26): 2473–2483.

3. Perren TJ, Swart AM, Pfisterer J et al. ICON7 Investigators. A phase 3 trial of bevacizumab in ovarian cancer. N Engl J Med 2011; 365(26): 2484–2896.

4. Aghajanian C, Finkler NJ, Rutherford T et al. OCEANS: A randomized, double-blinded, placebo-controlled phase III trial of chemotherapy with or without bevacizumab (BEV) in patients with platinum-sensitive recurrent epithelial ovarian (EOC), primary peritoneal (PPC), or fallopian tube cancer (FTC). 2012 ASCO Annual Meeting Abstract No: LBA5007.

5. Pujade-Lauraine E. AURELIA: A randomized phase III trial evaluating bevacizumab (BEV) plus chemotherapy (CT) for platinum (PT)-resistant recurrent ovarian cancer (OC). 2012 ASCO Annual Meeting Abstract No: LBA5002.

Labels

Paediatric clinical oncology Surgery Clinical oncology

Analysis of Prognostic Factors in Osteosarcoma Adult Patients, a Single Institution Experience

Neoplastic Effect of Indomethacin in N-methyl-N-nitrosourea Induced Mammary Carcinogenesis in Female Rats

Importance of Expression of DNA Repair Proteins in Non-Small-Cell Lung Cancer

Bloodstream Infections of the Intravascular Access Devices – Case Reports and Review of the Literature

Preoperative Radiotherapy of Locally Advanced Rectal Cancer: Clinical Outcome of Short-Course and Long-Course Treatment with or without Concomitant Chemotherapy

BRAF Mutation: a Novel Approach in Targeted Melanoma Therapy

The Substance of Genetic Information – Nucleic Acids

Dabrafenib: the New Inhibitor of Hyperactive B-RAF Kinase

Uterine Sarcomas – a Review

Article was published in

Clinical Oncology

2012 Issue 5